;PMID: 11782392
;source_file_2934.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..36] = [t:0..36]
;1)sentence:[e:42..148] = [t:42..148]
;2)section:[e:152..238] = [t:152..238]
;3)section:[e:242..354] = [t:242..354]
;4)sentence:[e:358..453] = [t:358..453]
;5)sentence:[e:454..581] = [t:454..581]
;6)sentence:[e:582..783] = [t:582..783]
;7)sentence:[e:784..985] = [t:784..985]
;8)sentence:[e:986..1117] = [t:986..1117]
;9)sentence:[e:1118..1217] = [t:1118..1217]
;10)sentence:[e:1218..1339] = [t:1218..1339]
;11)sentence:[e:1340..1441] = [t:1340..1441]
;12)section:[e:1445..1490] = [t:1445..1490]

;section 0 Span:0..36
;Cancer Res.  2002 Jan 1;62(1):301-6.
(SEC
  (FRAG (NNP:[0..6] Cancer) (NNP:[7..10] Res) (.:[10..11] .) ('':[13..17] 2002)
        (NNP:[18..21] Jan) (IN:[22..24] 1;) (CD:[24..27] 62-LRB-)
        (CD:[27..28] 1) (-RRB-:[28..29] -RRB-) (::[29..30] :) (CD:[30..33] 301)
        (CD:[33..36] -6.)))

;sentence 1 Span:42..148
;Id2 is critical for cellular proliferation and is the oncogenic effector of 
;N-myc in human neuroblastoma.
;[42..45]:gene-protein:"Id2"
;[119..124]:gene-rna:"N-myc"
;[134..147]:malignancy-type:"neuroblastoma"
(SENT
  (S-HLN
    (NP-SBJ (NN:[42..45] Id2))
    (VP
      (VP (VBZ:[46..48] is)
        (ADJP-PRD (JJ:[49..57] critical)
          (PP (IN:[58..61] for)
            (NP (JJ:[62..70] cellular) (NN:[71..84] proliferation)))))
      (CC:[85..88] and)
      (VP (VBZ:[89..91] is)
        (NP-PRD
          (NP (DT:[92..95] the) (JJ:[96..105] oncogenic)
              (NN:[106..114] effector))
          (PP (IN:[115..117] of)
            (NP (NN:[119..124] N-myc))))
        (PP-LOC (IN:[125..127] in)
          (NP (JJ:[128..133] human) (NN:[134..147] neuroblastoma)))))
    (.:[147..148] .)))

;section 2 Span:152..238
;Lasorella A, Boldrini R, Dominici C, Donfrancesco A, Yokota Y, Inserra A, 
;Iavarone A.
(SEC
  (FRAG (NNP:[152..161] Lasorella) (NNP:[162..163] A) (,:[163..164] ,)
        (NNP:[165..173] Boldrini) (NNP:[174..175] R) (,:[175..176] ,)
        (NNP:[177..185] Dominici) (NNP:[186..187] C) (,:[187..188] ,)
        (NNP:[189..201] Donfrancesco) (NNP:[202..203] A) (,:[203..204] ,)
        (NNP:[205..211] Yokota) (NNP:[212..213] Y) (,:[213..214] ,)
        (NNP:[215..222] Inserra) (NNP:[223..224] A) (,:[224..225] ,)
        (NNP:[227..235] Iavarone) (NNP:[236..237] A) (.:[237..238] .)))

;section 3 Span:242..354
;Department of Neurology, Albert Einstein College of Medicine, Bronx, New York
; 10461, USA. iavarone@aecom.yu.edu
(SEC
  (FRAG (NNP:[242..252] Department) (IN:[253..255] of)
        (NNP:[256..265] Neurology) (,:[265..266] ,) (NNP:[267..273] Albert)
        (NNP:[274..282] Einstein) (NNP:[283..290] College) (IN:[291..293] of)
        (NNP:[294..302] Medicine) (,:[302..303] ,) (NNP:[304..309] Bronx)
        (,:[309..310] ,) (NNP:[311..314] New) (NNP:[315..319] York)
        (CD:[321..326] 10461) (,:[326..327] ,) (NNP:[328..331] USA)
        (.:[331..332] .) ('':[333..354] iavarone@aecom.yu.edu)))

;sentence 4 Span:358..453
;Perturbation of the function of the retinoblastoma (Rb) protein is found in
;most  human tumors.
;[394..408]:gene-protein:"retinoblastoma"
;[410..412]:gene-protein:"Rb"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[358..370] Perturbation))
      (PP (IN:[371..373] of)
        (NP
          (NP (DT:[374..377] the) (NN:[378..386] function))
          (PP (IN:[387..389] of)
            (NP (DT:[390..393] the)
              (NML
                (NML (NN:[394..408] retinoblastoma))
                (NML (-LRB-:[409..410] -LRB-) (NN:[410..412] Rb)
                     (-RRB-:[412..413] -RRB-)))
              (NN:[414..421] protein))))))
    (VP (VBZ:[422..424] is)
      (VP (VBN:[425..430] found)
        (NP-1 (-NONE-:[430..430] *))
        (PP (IN:[431..433] in)
          (NP (JJS:[434..438] most) (JJ:[440..445] human)
              (NNS:[446..452] tumors)))))
    (.:[452..453] .)))

;sentence 5 Span:454..581
;Id2 is a natural target of the Rb protein that is recruited by Myc 
;oncoproteins to bypass the tumor suppressor function of Rb.
;[454..457]:gene-protein:"Id2"
;[485..487]:gene-protein:"Rb"
;[517..520]:gene-protein:"Myc"
;[578..580]:gene-protein:"Rb"
(SENT
  (S
    (NP-SBJ (NN:[454..457] Id2))
    (VP (VBZ:[458..460] is)
      (NP-PRD
        (NP
          (NP (DT:[461..462] a) (JJ:[463..470] natural) (NN:[471..477] target))
          (PP (IN:[478..480] of)
            (NP (DT:[481..484] the) (NN:[485..487] Rb) (NN:[488..495] protein))))
        (SBAR
          (WHNP-1 (WDT:[496..500] that))
          (S
            (NP-SBJ-1 (-NONE-:[500..500] *T*))
            (VP (VBZ:[501..503] is)
              (VP (VBN:[504..513] recruited)
                (NP-1 (-NONE-:[513..513] *))
                (PP (IN:[514..516] by)
                  (NP (NN:[517..520] Myc) (NNS:[522..534] oncoproteins)))
                (S-PRP
                  (NP-SBJ (-NONE-:[534..534] *))
                  (VP (TO:[535..537] to)
                    (VP (VB:[538..544] bypass)
                      (NP
                        (NP (DT:[545..548] the)
                          (NML (NN:[549..554] tumor) (NN:[555..565] suppressor))
                          (NN:[566..574] function))
                        (PP (IN:[575..577] of)
                          (NP (NN:[578..580] Rb)))))))))))))
    (.:[580..581] .)))

;sentence 6 Span:582..783
;Here we report that  an "N-Myc-Id2 pathway" persists during late development
;of the nervous system  and parallels the rising levels of active Rb in
;neuronal precursors withdrawing  from the cell cycle.
;[607..612]:gene-rna:"N-Myc"
;[613..616]:gene-protein:"Id2"
;[724..726]:gene-protein:"Rb"
(SENT
  (S
    (ADVP (RB:[582..586] Here))
    (NP-SBJ (PRP:[587..589] we))
    (VP (VBP:[590..596] report)
      (SBAR (IN:[597..601] that)
        (S
          (NP-SBJ (DT:[603..605] an) (``:[606..607] ")
            (NML (NN:[607..612] N-Myc) (HYPH:[612..613] -) (NN:[613..616] Id2))
            (NN:[617..624] pathway))
          ('':[624..625] ")
          (VP
            (VP (VBZ:[626..634] persists)
              (PP-TMP (IN:[635..641] during)
                (NP
                  (NP (JJ:[642..646] late) (NN:[647..658] development))
                  (PP (IN:[659..661] of)
                    (NP (DT:[662..665] the) (JJ:[666..673] nervous)
                        (NN:[674..680] system))))))
            (CC:[682..685] and)
            (VP (VBZ:[686..695] parallels)
              (NP
                (NP (DT:[696..699] the) (VBG:[700..706] rising)
                    (NNS:[707..713] levels))
                (PP (IN:[714..716] of)
                  (NP (JJ:[717..723] active) (NN:[724..726] Rb))))
              (PP (IN:[727..729] in)
                (NP
                  (NP (JJ:[730..738] neuronal) (NNS:[739..749] precursors))
                  (VP (VBG:[750..761] withdrawing)
                    (PP (IN:[763..767] from)
                      (NP (DT:[768..771] the) (NN:[772..776] cell)
                          (NN:[777..782] cycle)))))))))))
    (.:[782..783] .)))

;sentence 7 Span:784..985
;An immunohistochemical analysis of primary neuroblastoma  from 47 patients
;shows that expression of Id2 is strongly predictive of poor  outcome,
;irrespective of other clinical and biological variables.
;[819..826]:malignancy-clinical-stage:"primary"
;[827..840]:malignancy-type:"neuroblastoma"
;[884..887]:gene-protein:"Id2"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[784..786] An) (JJ:[787..806] immunohistochemical)
          (NN:[807..815] analysis))
      (PP (IN:[816..818] of)
        (NP
          (NP (JJ:[819..826] primary) (NN:[827..840] neuroblastoma))
          (PP (IN:[842..846] from)
            (NP (CD:[847..849] 47) (NNS:[850..858] patients))))))
    (VP (VBZ:[859..864] shows)
      (SBAR (IN:[865..869] that)
        (S
          (NP-SBJ
            (NP (NN:[870..880] expression))
            (PP (IN:[881..883] of)
              (NP (NN:[884..887] Id2))))
          (VP (VBZ:[888..890] is)
            (ADVP (RB:[891..899] strongly))
            (ADJP-PRD (JJ:[900..910] predictive)
              (PP (IN:[911..913] of)
                (NP
                  (NP (JJ:[914..918] poor) (NN:[920..927] outcome))
                  (,:[927..928] ,)
                  (ADJP (JJ:[929..941] irrespective)
                    (PP (IN:[942..944] of)
                      (NP (JJ:[945..950] other)
                        (ADJP (JJ:[951..959] clinical) (CC:[960..963] and)
                              (JJ:[964..974] biological))
                        (NNS:[975..984] variables)))))))))))
    (.:[984..985] .)))

;sentence 8 Span:986..1117
;Overexpression  of Id2 mediates cellular transformation and is required to
;maintain the  malignant behavior of neuroblastoma cells.
;[1005..1008]:gene-protein:"Id2"
;[1097..1110]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[986..1000] Overexpression))
      (PP (IN:[1002..1004] of)
        (NP (NN:[1005..1008] Id2))))
    (VP
      (VP (VBZ:[1009..1017] mediates)
        (NP (JJ:[1018..1026] cellular) (NN:[1027..1041] transformation)))
      (CC:[1042..1045] and)
      (VP (VBZ:[1046..1048] is)
        (VP (VBN:[1049..1057] required)
          (NP-1 (-NONE-:[1057..1057] *))
          (S
            (NP-SBJ (-NONE-:[1057..1057] *))
            (VP (TO:[1058..1060] to)
              (VP (VB:[1061..1069] maintain)
                (NP
                  (NP (DT:[1070..1073] the) (JJ:[1075..1084] malignant)
                      (NN:[1085..1093] behavior))
                  (PP (IN:[1094..1096] of)
                    (NP (NN:[1097..1110] neuroblastoma) (NNS:[1111..1116] cells))))))))))
    (.:[1116..1117] .)))

;sentence 9 Span:1118..1217
;Correspondingly, embryonic  fibroblasts from Id2-null mice display impaired
;ability to proliferate.
;[1163..1167]:gene-protein:"Id2-"
(SENT
  (S
    (ADVP (RB:[1118..1133] Correspondingly))
    (,:[1133..1134] ,)
    (NP-SBJ
      (NP (JJ:[1135..1144] embryonic) (NNS:[1146..1157] fibroblasts))
      (PP (IN:[1158..1162] from)
        (NP
          (ADJP
             (NN:[1163..1166] Id2) (HYPH:[1166..1167] -)
            (JJ:[1167..1171] null))
          (NNS:[1172..1176] mice))))
    (VP (VBP:[1177..1184] display)
      (NP (VBN:[1185..1193] impaired) (NN:[1194..1201] ability)
        (S
          (NP-SBJ (-NONE-:[1201..1201] *))
          (VP (TO:[1202..1204] to)
            (VP (VB:[1205..1216] proliferate))))))
    (.:[1216..1217] .)))

;sentence 10 Span:1218..1339
;We  suggest that Id2 overexpression may be a better prognostic indicator than
;N-myc  gene amplification in neuroblastoma.
;[1235..1238]:gene-protein:"Id2"
;[1296..1301]:gene-rna:"N-myc"
;[1308..1321]:variation-type:"amplification"
;[1325..1338]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (PRP:[1218..1220] We))
    (VP (VBP:[1222..1229] suggest)
      (SBAR (IN:[1230..1234] that)
        (S
          (NP-SBJ (NN:[1235..1238] Id2) (NN:[1239..1253] overexpression))
          (VP (MD:[1254..1257] may)
            (VP (VB:[1258..1260] be)
              (NP-PRD
                (NP (DT:[1261..1262] a) (JJR:[1263..1269] better)
                    (JJ:[1270..1280] prognostic) (NN:[1281..1290] indicator))
                (PP (IN:[1291..1295] than)
                  (NP (NN:[1296..1301] N-myc) (NN:[1303..1307] gene)
                      (NN:[1308..1321] amplification))))
              (PP (IN:[1322..1324] in)
                (NP (NN:[1325..1338] neuroblastoma))))))))
    (.:[1338..1339] .)))

;sentence 11 Span:1340..1441
;Thus, disrupting Id2 function may lead to  new and useful therapeutic
;strategies for cancer patients.
;[1357..1360]:gene-protein:"Id2"
(SENT
  (S
    (ADVP (RB:[1340..1344] Thus))
    (,:[1344..1345] ,)
    (NP-SBJ (VBG:[1346..1356] disrupting) (NN:[1357..1360] Id2)
            (NN:[1361..1369] function))
    (VP (MD:[1370..1373] may)
      (VP (VB:[1374..1378] lead)
        (PP-CLR (TO:[1379..1381] to)
          (NP
            (NP
              (ADJP (JJ:[1383..1386] new) (CC:[1387..1390] and)
                    (JJ:[1391..1397] useful))
              (JJ:[1398..1409] therapeutic) (NNS:[1410..1420] strategies))
            (PP (IN:[1421..1424] for)
              (NP (NN:[1425..1431] cancer) (NNS:[1432..1440] patients)))))))
    (.:[1440..1441] .)))

;section 12 Span:1445..1490
;PMID: 11782392 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1445..1449] PMID) (::[1449..1450] :) (CD:[1451..1459] 11782392)
        (NN:[1460..1461] -LSB-) (NNP:[1461..1467] PubMed) (::[1468..1469] -)
        (NN:[1470..1477] indexed) (IN:[1478..1481] for)
        (NNP:[1482..1490] MEDLINE-RSB-)))
